Columbia University Institute for Cancer Genetics
Examining the molecular mechanisms and pathogenesis of cancer using traditional approaches, such as transgenic mice, to model human cancers as well as new technology, such as DNA Chip microarrays, to identify and characterize key proteins involved in the process of tumor initiation and progression.